Specialty code 1835P1200X · Roseville, CA
NPI
1679871636
Since 2011
Specialty
Specialty code 1835P1200X
Code 1835P1200X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1600 Eureka Rd
Roseville, CA, 95661
Phone (916) 784-4050
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$920K
412 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kasey L Flores prescribed most often to Medicare patients was Amjevita(Cf) Autoinjector (Adalimumab-Atto), with 129 prescriptions and refills. In total Kasey L Flores wrote 412 Medicare prescriptions that cost $920K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 129 | 210 | 40 | $200K |
| Methotrexate Methotrexate Sodium | 52 | 146 | 28 | $1,392 |
| Otezla Apremilast | 43 | 43 | Under 11 | $190K |
| Orencia Clickject Abatacept | 39 | 39 | Under 11 | $179K |
| Xeljanz Tofacitinib Citrate | 22 | 22 | Under 11 | $51K |
| Hydroxychloroquine Sulfate Generic | 19 | 63 | Under 11 | $625 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 16 | 16 | Under 11 | $51K |
| Amjevita(Cf) Adalimumab-Atto | 12 | 19 | Under 11 | $23K |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 12 | 28 | Under 11 | $90.02 |
| Rasuvo Methotrexate/Pf | 11 | 11 | Under 11 | $4,272 |
Brand drugs: 328 claims; generic drugs: 72 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kasey L Flores were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.